8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 or 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): September 3, 2019

Rennova Health, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

001-35141	68-0370244
(Commission File Number)	(I.R.S. Employer Identification No.)

400 S. Australian Avenue, Suite 800, West Palm Beach, Florida	33401
(Address of Principal Executive Offices)	(Zip Code)

(561) 855-1626

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company [  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

Item 7.01. Regulation FD Disclosure

On September 3, 2019, Rennova Health, Inc. (the “Company”) issued a press release announcing that Seamus Lagan, our Chief Executive Officer, would be interviewed on Uptick Newswire’s “Stock Day” podcast with Everett Jolly. A copy of the press release is attached hereto as Exhibit 99.1 and a transcript of the interview is attached hereto as Exhibit 99.2.

The information furnished pursuant to this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

Exhibit No.	Exhibit Description
99.1	Press Release dated September 3, 2019
99.2	Transcript of Interview of Seamus Lagan

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 3, 2019	RENNOVA HEALTH, INC.
	By:	/s/ Seamus Lagan
		Seamus Lagan
		Chief Executive Officer
		(principal executive officer)

3

EX-99.1

rennova health discusses the intergration of their facilities with the stock day podcast

WEST PALM BEACH, Fla. (September 3, 2019) – Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that acquired Jellico Community Hospital, its third rural hospital in Tennessee, at the beginning of March 2019, announces that Rennova CEO and President of the Company, Seamus Lagan, joined Stock Day host Everett Jolly for a business update.

Jolly began the interview by asking Lagan about when the Company’s financials will be up-to-date and filed. Lagan explained that the Company’s auditors were currently on site completing the testing for the audit. “If possible, we want to be compliant by the end of September.”, explained Lagan. He added that the Company has made changes to their financial team throughout the year and is finally seeing results. “I think, Everett, that the important thing is that once we get these numbers out, we’ll be presenting Rennova in a very different form.”

Jolly then inquired about the Company’s recent announcement about receiving the change of ownership approvals required to generate their claims to get paid for Jellico. Mr. Lagan shared that this process was lengthy, having taken approximately six months through which the Company had to carry the costs without income. He also noted that the Medicare funds, which account for 60% to 70% of the revenue have not yet come through. This totals millions of dollars that the Company is looking forward to receiving in the next couple of weeks.

Jolly followed by asking Lagan what the fourth quarter of 2020 may look like. Lagan stated that the Company’s focus for the remainder of the year will be on the integration of their current acquisitions, which include numerous hospitals and clinics. Considering the facilities’ close geographic locations, Lagan explained that the Company expects annual revenues of $50 million or more by the end of 2020. “That’s our ambition and that’s what we’re targeting.” stated Lagan.

Lagan then shared news about the Company’s Jamestown facility, which has recently received approval for the reinstatement of its Medicare agreement. He explained that the Company is currently making plans to reopen the facility.

To close the interview, Lagan expressed his excitement for the Company’s opportunity to operate their unique rural business model. He also explained that the period of losses incurred by their transition into this model are coming to an end, adding that the Company will now focus on becoming compliant and fully transparent for its shareholders. “I think that everybody will recognize us as a very different company in the near future.”, Lagan closed.

To hear Seamus Lagan’s entire interview, follow the link to the podcast here:

https://audioboom.com/posts/7357594-rennova-health-inc-discusses-the-integration-of-their-facilities-with-the-stock-day-podcast

About Rennova Health, Inc.

Rennova operates three rural hospitals and a physician’s office in Tennessee and a physician’s office in Kentucky and provides industry-leading diagnostics and supportive software solutions to healthcare providers. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

Contacts:

Rennova Health

Sebastien Sainsbury, 561-666-9818

ssainsbury@rennovahealth.com

# # #

EX-99.2

Rennova Health Interview

CEO Seamus Lagan on Uptick Newswire September 2019

Speakers: Everett Jolly and Seamus Lagan

Jolly: On today’s show I’m bringing back a returning guest that was on my show back in June of 2019. We’re talking no other than Rennova Health, Inc. I’ll tell you what, if it was easy being a CEO everybody would quit their day job and become a CEO. It’s not an easy task to take on three hospitals. If you remember, my guest has been on the show many, many times. The first hospital they took over in Tennessee, he said at that time that they were going to take over two, now they’re at three. You can find them on the OTCQB, their ticker symbol is “RNVA”. With us today is the CEO and President of the Company - he’s going to bring us up to speed on what’s been going on with his company - Mr. Seamus Lagan. Seamus, welcome back to the show. We greatly appreciate it.

Lagan: Everett, thank you. Just for correction, we’re not on the OTCQB at the moment - it’s just OTC until we get our financials all up-to-date again. But, thank you for having me back.

Jolly: Thank you for the correction. I really do appreciate it. Let’s talk about financials. Where are we at on the financial statements? When is that going to be up to date and when are you going to be filing that?

Lagan: Everybody is very aware of how late we’ve been this year in getting everything completed and filed. Thankfully, as we speak, our auditors are on-site at the hospitals. They’re doing their tests and finishing up. So I expect it very shortly. I don’t want to commit to a time and miss it again, but it’s a matter of weeks. We’re not far away now from filing the audit and following it up very quickly with the Qs and getting ourselves back in compliance. If at all possible, we want to be compliant by the end of September. There’s a lot of work to do, but that’s where we’re at. We’ve changed the financial team throughout the year and it’s starting to function very well for us. I think, Everett, the important thing is that once we get these numbers out, we will be presenting Rennova in a very different form from the one that everyone’s had to look at for the past two years. So, we’re very much looking forward to getting those numbers out.

Jolly: Here’s what I do know. I know that you’ve been on my show for a couple of years. You told me that you were going to purchase a hospital - you did. You told me you were going to purchase a second hospital - you did. Now we’re looking at number three and I see recently that you just made the announcement of your third acquisition and it has received all of the approvals required to generate your claims to get paid. So, where do we go from here?

Lagan: That was a long haul for us - it took almost six months. There’s a lot of I’s to dot and T’s to cross.

Jolly: Absolutely.

Lagan: Fortunately, the approvals are all retrospective to the date that we took ownership. So, we can now drop all of our claims from March forward. Listen, those are the challenges for a CEO and all of the team. There was a definite cash crunch throughout that period of time and thankfully our bankers stepped up and helped us again. But, we’re looking forward to getting some of that money in the door and being able to function normally. Anybody in the healthcare sector realizes that to operate particularly a hospital for six months without being able to bill or get paid is a significant cash burden. Now that we’re about over that, things should get a lot easier for us on a daily basis. There’s been a little money starting to come in, to answer your question. However, the Medicare money, they’re a big portion of that business - 60%-70% - none of that is in yet. So, that’s a few million dollars, Everett. We very much look forward to getting it in.

Jolly: What’s so great about it is that you’ve been buying these properties at the right price. We can’t get into the semantics about how you did it, but if you can do a run rate of $30 million, which I think you possibly could, what does the future look like by the end of the fourth quarter in 2020?

Lagan: In 2020? Well, we obviously have no numbers out there at the minute, but the plan right now is to get the existing facilities integrated. As you’ve mentioned, we’ve had three facilities in a fairly close geographic location with a lot of efficiency and ability to share services and share senior management. The integration of those acquisitions is ongoing and progressing very well. I would expect a run rate at the end of this year around that 30 or higher, hopefully higher. However, I want to caveat that by saying that the ambition would be to have those facilities doing approximately $50 million or more if possible by the end of 2020. I think it’s very possible. We’ve continually stated it’s a needed service. The opportunity with the hospitals being close together would allow us to do those types of numbers, Everett. That’s our ambition, that’s what we hope to achieve, and that’s what we’re targeting.

Jolly: I saw that the Jamestown facility got approved for the reinstatement of its Medicare agreement. What happens next and will that facility reopen?

Lagan: So, that’s been the unexpected thing that we’ve had to deal with this year. It’s been a little bump in the road, so to speak. But, we did get those approvals and the CEO on-site, the new CEO, is currently making plans to reopen and facilitate the inspection that is required to finish that approval process. We don’t have a date fixed as we speak, but that will be in September. We expect that to be in September. I don’t see any reason why it won’t be. We’ll be as quick as possible about getting through the process with CMS to get the Medicare agreement reinstated and get back to normal business. That will be the hurdle to get over well before year-end and will facilitate the numbers we spoke of earlier. So, if we can just consolidate and complete the integration of these acquisitions throughout the rest of this year, get the company compliant again and reporting...There’s a lot going on at a corporate level that is pretty exciting for the future and I think that we have a great opportunity over the next few years once we get over the next few months. It’s as simple as that.

Jolly: Before I let you go, for your stockholders, what do you want them to take away from this interview?

Lagan: I think it’s almost a repeat of what I’ve said before. The history, when people look at the filings and the financial history, has been difficult. I believe the transition to the rural hospital model is pretty well complete. This year we’ll see these three hospitals and the two clinics functioning as we expect them to. I think that the opportunity going forward to operate this model is what the shareholders should be looking at. I really do believe that the worst of the restructuring and the losses incurred over the couple of years transitioning into this model are behind us. We have to get compliant and get that transparency or become transparent again to the investment community, but I do think that everybody will recognize us as a very different company in the very near future.

Jolly: My guest today has been Seamus Lagan. He is the CEO and President of Rennova Health, Inc. You can find them on the OTC markets under the ticker symbol “RNVA”. I still think it’s grossly undervalued here. I want to thank you, Seamus, for coming on the show. I know you’re a busy guy. You’ve got 20,000 things going on your plate and taking time out to come on this show is always appreciated. I know you’ll work things out. You’re a winner, I believe in you and what you’re doing out there. Just keep doing what you’re doing.

Lagan: I appreciate that very much, thank you.